Inventor
NAIR JAYAPRAKASH K
US34 patents
⚠️ This page may combine multiple inventors who share the name “NAIR JAYAPRAKASH K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
26 patentsUS9682922B2Jun 20, 2017
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC39 citations94
US11504391B1Nov 22, 2022
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC18 citations84
US10995336B2May 4, 2021
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC8 citations83
US10808246B2Oct 20, 2020
Oligonucleotide-ligand conjugates and process for their preparation
ALNYLAM PHARMACEUTICALS INC6 citations83
US10086081B2Oct 2, 2018
Carbohydrate conjugated RNA agents and process for their preparation
ALNYLAM PHARMACEUTICALS INC11 citations83
US9566340B2Feb 14, 2017
Monomers and oligonucleotides comprising cycloaddition adduct(s)
ALNYLAM PHARMACEUTICALS INC11 citations83
US12364762B2Jul 22, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US12350338B2Jul 8, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US12343398B2Jul 1, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US12239709B2Mar 4, 2025
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations73
US11666653B2Jun 6, 2023
Carbohydrate conjugates as delivery agents for oligonucleotides
ALNYLAM PHARMACEUTICALS INC1 citations73
US9701623B2Jul 11, 2017
Di-aliphatic substituted pegylated lipids
ALNYLAM PHARMACEUTICALS INC5 citations73
US11597932B2Mar 7, 2023
Chirally-enriched double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC3 citations70
US12059468B2Aug 13, 2024
Carbohydrate conjugates as delivery agents for oligonucleotides
ALNYLAM PHARMACEUTICALS INC0 citations63
US12275938B2Apr 15, 2025
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC0 citations62
US12247203B2Mar 11, 2025
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC0 citations62
US12221607B2Feb 11, 2025
Multi-targeted single entity conjugates
ALNYLAM PHARMACEUTICALS INC0 citations62
US12173288B2Dec 24, 2024
Oligonucleotide-ligand conjugates and process for their preparation
ALNYLAM PHARMACEUTICALS INC0 citations62
US11944687B2Apr 2, 2024
Carbohydrate conjugate RNA agents and process for their preparation
ALNYLAM PHARMACEUTICALS INC0 citations62
US11725207B2Aug 15, 2023
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC1 citations62
US11053495B2Jul 6, 2021
Multi-targeted single entity conjugates
ALNYLAM PHARMACEUTICALS INC0 citations62
US12397013B2Aug 26, 2025
Extrahepatic delivery
ALNYLAM PHARMACEUTICALS INC0 citations61
US12005074B2Jun 11, 2024
Extrahepatic delivery
ALNYLAM PHARMACEUTICALS INC0 citations61
US10266484B2Apr 23, 2019
Biodegradable lipids for the delivery of active agents
ALNYLAM PHARMACEUTICALS INC0 citations52
US10550386B2Feb 4, 2020
Monomers and oligonucleotides comprising cycloaddition adduct(s)
ALNYLAM PHARMACEUTICALS INC0 citations51
US11286482B2Mar 29, 2022
Endosomal cleavable linkers
ALNYLAM PHARMACEUTICALS INC0 citations46
ARBUTUS BIOPHARMA CORP
7 patentsUS9682139B2Jun 20, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP46 citations98
US9814777B2Nov 14, 2017
Targeting lipids
ARBUTUS BIOPHARMA CORP8 citations93
US10117941B2Nov 6, 2018
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP12 citations92
US9764036B2Sep 19, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP19 citations92
US10821186B2Nov 3, 2020
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP4 citations84
US11420931B2Aug 23, 2022
Lipid containing formulations
ARBUTUS BIOPHARMA CORP2 citations73
US10835612B2Nov 17, 2020
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations52